Briston Phillip, Sinclair David
Department of Chemical Pathology, Queen Alexandra Hospital, Portsmouth, UK.
Clin Lab. 2004;50(7-8):383-6.
Assessment of thyroid antibody status can influence the decision to commence thyroxine replacement in patients with persistent marginally raised TSH concentrations. We studied 211 patients in whom we had reported a slightly raised TSH on two or more occasions. The most recent result was accompanied by a suggestion to repeat the TSH estimation and request thyroid antibodies. Although we received follow-up specimens on 59% of the audit sample, antibodies were requested on only 37%. However, a majority (62%) of those specimens showed a raised antibody concentration and this appeared to influence the decision to start thyroxine replacement. Our data suggest that it would be more effective if laboratory staff were to request thyroid antibodies on specimens from patients with persistently raised TSH concentrations and to comment further on the significance of the result.
评估甲状腺抗体状态会影响对促甲状腺激素(TSH)浓度持续轻度升高的患者开始进行甲状腺素替代治疗的决策。我们研究了211例患者,这些患者的TSH在两次或更多次检查中被报告为轻度升高。最近一次结果还建议重复进行TSH测定并检测甲状腺抗体。尽管我们收到了59%的审计样本的后续标本,但仅37%的标本检测了抗体。然而,这些标本中的大多数(62%)显示抗体浓度升高,这似乎影响了开始甲状腺素替代治疗的决策。我们的数据表明,如果实验室工作人员对TSH浓度持续升高的患者的标本检测甲状腺抗体,并对结果的意义进行进一步说明,可能会更有效。